Clinical Trials Sponsored by Guangxi Medical University

Total 30947 results

Guangxi Medical University

Recruiting

EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumor | Multiple Endocrine Neoplasia Type 1

China
Guangxi Medical University

Recruiting

HR Versus RFA for HCC in Patients With PHT (HR-HCC/PHT)

Neoplasms, Glandular and Epithelial | Carcinoma, Hepatocellular | Liver Neoplasms

China
Guangxi Medical University

Completed

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC (FRONT-1)

Liver Cancer

China
Guangxi Medical University

Completed

Simo Decoction and Gum Chewing for Bowel Activity (SD/GC-HCC)

Hepatocellular Carcinoma

China
Guangxi Medical University

Completed

Evaluation of a Psychological Capital Intervention to Alleviate Burnout and Regulate Immunity Among Oncology Nurses

Burnout | Psychological

China
Guangxi Medical University

Unknown

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Hepatocellular Carcinoma

China
Guangxi Medical University

Withdrawn

Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma

Hepatocellular Carcinoma
Guangxi Medical University

Withdrawn

Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma
Guangxi Medical University

Withdrawn

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Hepatocellular Carcinoma
Guangxi Medical University

Unknown

The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus

Hepatocellular Carcinoma
Guangxi Medical University

Unknown

The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma
Guangxi Medical University

Unknown

Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications (RDSA)

HepatoCellular Carcinoma

China
Guangxi Medical University

Unknown

Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis (RHCC)

HepatoCellular Carcinoma

China
Guangxi Medical University

Unknown

EUS-guided Ethanol Ablation of an Insulinoma (EUS)

Insulinoma

China
Guangxi Medical University

Unknown

the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient (IDBUCY)

Acute Myeloid Leukemia

China
Guangxi Medical University

Completed

Study on the Evolution of Genes Mutation Related With Gastrointestinal Stromal Tumors

Full Gene Sequences of c-KIT、PDGFRA and DOG1 Are Analyzed With the Screening-sequencing Approach | Investigate the Characteristics and Variations Associated With the Different Gene Mutations of c-KIT、PDGFRA and DOG1 in GIST Patients
Guangxi Medical University

Recruiting

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Guangxi Medical University

Not yet recruiting

Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation (PREVENT-2)

Recurrence | Hepatocellular Carcinoma | Immune Checkpoint Inhibitor

China
Guangxi Medical University

Recruiting

Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma

Gastric Cancer | GastroEsophageal Cancer | Fruquintinib | SOX

China
Guangxi Medical University

Recruiting

DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Guangxi Medical University

Not yet recruiting

Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma

Hepatocellular Carcinoma
Guangxi Medical University

Completed

Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

Hepatocellular Carcinoma

China
Guangxi Medical University

Completed

Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection (SP/GC-HCC)

Liver Cancer

China
Guangxi Medical University

Completed

Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Guangxi Medical University

Unknown

Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

Advanced Liver Cancer

China
Guangxi Medical University

Withdrawn

FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer

Rectal Cancer

China
Guangxi Medical University

Withdrawn

Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma (LD-FOX4/HCC)

Hepatocellular Carcinoma
Guangxi Medical University

Unknown

Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion (RHCC:BCLC-A)

HepatoCellular Carcinoma

China
Guangxi Medical University

Unknown

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

Lymphoma

China
Guangxi Medical University

Unknown

Study of DC-CIK to Treat Colorectal Cancer

Colorectal Cancer

China
Guangxi Medical University

Unknown

Study of DC-CIK to Treat NPC

Nasopharyngeal Carcinoma

China
Guangxi Medical University

Unknown

A Study of DC-CIK to Treat Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

China
Guangxi Medical University

Not yet recruiting

Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of Ovary

China
Guangxi Medical University

Not yet recruiting

Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Immune Checkpoint Inhibitors
Guangxi Medical University

Not yet recruiting

Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

Hepatocellular Carcinoma
Guangxi Medical University

Recruiting

EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumor | Nonfunctional Pancreatic Neuroendocrine Tumor | Endoscopic Ultrasound

China
Guangxi Medical University

Not yet recruiting

Hearing Toxicity of Nasopharyngeal Carcinoma After Chemoradiotherapy

Nasopharyngeal Carcinoma
Guangxi Medical University

Recruiting

Adjuvant Radiotherapy Comparing TACE for Curative HCC (ARTC-HCC)

Hepatocellular Carcinoma

China
Guangxi Medical University

Completed

TACE Combined With Donafenib and Tislelizumab in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Guangxi Medical University

Completed

Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection (AT/HCC)

Liver Cancer

China
Guangxi Medical University

Unknown

Albumin for Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hypoproteinemia

China
Guangxi Medical University

Unknown

HR Versus RFA for Early Stage HCC (ARTC-HCC)

Hepatocellular Carcinoma | Liver Cancer

China
Guangxi Medical University

Unknown

Adjuvant Therapies for Patients With HCC and MVI (A-TACE/S-HCC)

Hepatocellular Carcinoma

China
Guangxi Medical University

Unknown

RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)

Hepatocellular Carcinoma
Guangxi Medical University

Unknown

Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Guangxi Medical University

Unknown

Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

HepatoCellular Carcinoma

China
Guangxi Medical University

Completed

The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma (PMRIL)

Lymphoma

China
Guangxi Medical University

Unknown

Celebrex and Metformin for Postoperative Hepatocellular Carcinoma (XBD)

Liver Cancer

China
Guangxi Medical University

Completed

Effects of Antiviral Therapy on HBV Reactivation (HBV-DNA(-))

Liver Cancer
Guangxi Medical University

Unknown

Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients

Carcinoma, Hepatocellular

3

Subscribe